(Q37593172)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Recent advances and hurdles in melanoma immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Daniel Speiser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Pedro Romero

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

7 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

Pigment Cell & Melanoma Research

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

711-723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2009.00634.X

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-04-1364

Identifiers

DOI

10.1111/J.1755-148X.2009.00634.X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19735459%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference